Cargando…

Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer

BACKGROUND: A kinase-interacting protein 1 (AKIP1) has been reported to play an important role in the development and progression of cancer. However, the clinicopathological and biological roles of AKIP1 in colorectal cancer (CRC) remain largely unknown. The aim of this study was to investigate AKIP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Weifang, Yang, Weiji, Yuan, Li, Liu, Fanlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188170/ https://www.ncbi.nlm.nih.gov/pubmed/30349312 http://dx.doi.org/10.2147/OTT.S151952

Ejemplares similares

Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer
por: Han, Qiang, et al.
Publicado: (2019)

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer
por: Wang, Ping, et al.
Publicado: (2021)

Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma
por: Zhang, Qi, et al.
Publicado: (2021)

Cell-Penetrating Peptides Predicted From CASC3, AKIP1, and AHRR Proteins
por: Porosk, Ly, et al.
Publicado: (2021)

Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2019)

Silencing of AKIP1 Suppresses the Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Glioma Cells by Upregulating DLG2
por: Chen, Zhaohui, et al.
Publicado: (2022)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen, Xiaogang, et al.
Publicado: (2017)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer
por: Deng, Yu, et al.
Publicado: (2022)

AKIP1 Expression Modulates Mitochondrial Function in Rat Neonatal Cardiomyocytes
por: Yu, Hongjuan, et al.
Publicado: (2013)

Correction to: Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2022)

Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients
por: Liao, Li, et al.
Publicado: (2019)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration
por: Li, Qiuli, et al.
Publicado: (2020)

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer
por: Zong, Zhen, et al.
Publicado: (2016)

Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance
por: Tang, Huaping, et al.
Publicado: (2021)

MiR-320 regulates cardiomyocyte apoptosis induced by ischemia–reperfusion injury by targeting AKIP1
por: Tian, Zhi-Qiang, et al.
Publicado: (2018)

Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
por: Wu, Fan, et al.
Publicado: (2017)

Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis
por: Bai, Xiuhui, et al.
Publicado: (2021)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

Upregulated NLGN1 predicts poor survival in colorectal cancer
por: Yu, Qian, et al.
Publicado: (2021)

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression
por: Liao, Wen-Ting, et al.
Publicado: (2009)

Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2019)

Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients
por: Zhang, Qian, et al.
Publicado: (2015)

Association of tricellulin expression with poor colorectal cancer prognosis and metastasis
por: Zhang, Jin-Xiu, et al.
Publicado: (2020)

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
por: Qiu, Zhaoyan, et al.
Publicado: (2020)

Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2017)

Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients
por: Lim, Jaejoon, et al.
Publicado: (2019)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2021)

Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome
por: Tian, Haiying, et al.
Publicado: (2017)

Retraction Notice to: Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration
por: Li, Qiuli, et al.
Publicado: (2022)

Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer
por: Chen, Rui, et al.
Publicado: (2021)

Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
por: Xie, Chan, et al.
Publicado: (2012)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis
por: Peng, Xingyu, et al.
Publicado: (2023)

Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis
por: Moon, Ahrim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rdmj8k844622vulnuqak1qqa5d